Metagenomi, Inc. Revenue 2023–2025
Metagenomi, Inc. annual/quarterly revenue history and growth rate from 2023 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Metagenomi, Inc. revenue for the quarter ending March 31, 2026 was 1.2 M, a 69.76% decrease year-over-year.
- Metagenomi, Inc. revenue for the twelve months ending March 31, 2026 was 22.5 M, a 59.04% decrease year-over-year.
- Metagenomi, Inc. annual revenue for 2025 was 25.2 M, a 51.79% decrease from 2024.
- Metagenomi, Inc. annual revenue for 2024 was 52.3 M, a 16.84% increase from 2023.
- Metagenomi, Inc. annual revenue for 2023 was 44.8 M.
Metagenomi, Inc. (MGX) — Frequently Asked Questions
Metagenomi, Inc. (MGX) is a publicly traded US company. It has a market capitalization of $47M. In fiscal 2025 it reported revenue of $25M and net income of -$88M. Explore MGX's stock price, financial statements, earnings history, margins and key ratios below.
What is Metagenomi, Inc.'s market cap?
Metagenomi, Inc. (MGX) has a market capitalization of $47M.
What is the MGX stock price?
MGX trades at $1.25 (+1.63% on the day).
How much revenue does Metagenomi, Inc. make?
Metagenomi, Inc. reported revenue of $25M in fiscal 2025.
Is MGX profitable?
In fiscal 2025, Metagenomi, Inc. reported net income of -$88M.